Literature DB >> 34044608

Effects of lyoprotectants on long-term stability and transfection efficacy of lyophilized poly(lactide-co-glycolide)-graft-polyethylenimine/plasmid DNA polyplexes.

Joshua Woo1, Jeoung Soo Lee1.   

Abstract

Aim: We investigated the effect of lyoprotectants on the long-term stability and transfection efficiency of lyophilized (Lyo.) polyplexes prepared from poly(lactide-co-glycolide)-graft-polyethylenimine (PgP) and plasmid DNA encoding green fluorescent protein (pGFP). Materials & methods: Lyo. PgP/pGFP polyplexes prepared with/without lyoprotectants were stored at -20°C over 6 months. Polyplex stability was analyzed by gel electrophoresis and heparin competition assay. Transfection efficiency and cytotoxicity were evaluated in rat glioma (C6) cells in medium containing 10% serum.
Results: Lyo. PgP/pGFP polyplexes prepared with 5% sucrose as a lyoprotectant remained stable up to 6 months and retained transfection efficiency up to 4 months.
Conclusion: Lyo. PgP-based polyplexes retain bioactivity during extended storage, potentially enabling transport to remote regions and less stable settings, increasing access to life-changing gene therapy.

Entities:  

Keywords:  cationic amphiphilic polymer; gene delivery; long-term shelf life; lyophilization; lyoprotectants; nanoparticles; polymeric micelle

Mesh:

Substances:

Year:  2021        PMID: 34044608      PMCID: PMC8293032          DOI: 10.2217/nnm-2021-0065

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  37 in total

1.  RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model.

Authors:  So-Jung Gwak; Christian Macks; Da Un Jeong; Mark Kindy; Michael Lynn; Ken Webb; Jeoung Soo Lee
Journal:  Biomaterials       Date:  2017-01-03       Impact factor: 12.479

Review 2.  Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery.

Authors:  Nobuhiro Nishiyama; Kazunori Kataoka
Journal:  Pharmacol Ther       Date:  2006-07-11       Impact factor: 12.310

3.  Lyophilization of nonviral gene delivery systems.

Authors:  S D Allison; T J Anchordoquy
Journal:  Methods Mol Med       Date:  2001

4.  Noninvasive, targeted gene therapy for acute spinal cord injury using LIFU-mediated BDNF-loaded cationic nanobubble destruction.

Authors:  Zhaojun Song; Yongjie Ye; Zhi Zhang; Jieliang Shen; Zhenming Hu; Zhigang Wang; Jiazhuang Zheng
Journal:  Biochem Biophys Res Commun       Date:  2018-01-31       Impact factor: 3.575

Review 5.  Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges.

Authors:  Marina Cavazzana; Frederic D Bushman; Annarita Miccio; Isabelle André-Schmutz; Emmanuelle Six
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

Review 6.  Cardiovascular Gene Therapy: Past, Present, and Future.

Authors:  Seppo Ylä-Herttuala; Andrew H Baker
Journal:  Mol Ther       Date:  2017-04-04       Impact factor: 11.454

Review 7.  Gene therapy strategies for the treatment of spinal cord injury.

Authors:  Kenzo Uchida; Hideaki Nakajima; Alexander Rodriguez Guerrero; William Eb Johnson; Wagih El Masri; Hisatoshi Baba
Journal:  Ther Deliv       Date:  2014-05

Review 8.  New and emerging targeted therapies for cystic fibrosis.

Authors:  Bradley S Quon; Steven M Rowe
Journal:  BMJ       Date:  2016-03-30

9.  Local delivery of RhoA siRNA by PgP nanocarrier reduces inflammatory response and improves neuronal cell survival in a rat TBI model.

Authors:  Christian Macks; DaUn Jeong; Jeoung Soo Lee
Journal:  Nanomedicine       Date:  2020-11-28       Impact factor: 5.307

10.  Physicochemical stability and transfection efficiency of cationic amphiphilic copolymer/pDNA polyplexes for spinal cord injury repair.

Authors:  So-Jung Gwak; Christian Macks; Sooneon Bae; Noah Cecil; Jeoung Soo Lee
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more
  1 in total

1.  A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects.

Authors:  Bei Cheng; Hye-Hyun Ahn; Hwanhee Nam; Zirui Jiang; Feng J Gao; Il Minn; Martin G Pomper
Journal:  Pharmaceutics       Date:  2022-02-07       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.